Form 4 for RNXT RenovoRx, Inc.
Accepted 2026-03-24 00:00:00 ET · period of report 2026-03-20 · accession 0001493152-26-012481 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-03-24 | 2026-03-20 | RNXT | VOLL MARK | CFO | P - Purchase | — | +97.2K | 97.2K | New | — |
| DI | 2026-03-24 | 2026-03-20 | RNXT | VOLL MARK | CFO | P - Purchase | — | +48.6K | 48.6K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-20 | P | A | 97,200 | — | 97,200 | I Voll Family Trust DTD 6/23/2010 Mark Voll TTEE | — | — | (F1) The securities were purchased in a private placement on March 20, 2026 for an aggregate of $100,000. |
| 2 | Derivative | Warrants | 2026-03-20 | P | A | 48,600 | — | 48,600 | I Voll Family Trust DTD 6/23/2010 Mark Voll TTEE | $1.93 · — to — | 48,600 Common Stock | (F1) The securities were purchased in a private placement on March 20, 2026 for an aggregate of $100,000. (F2) The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report. |